JD Supra September 15, 2023
McDermott Will & Emery

As macroeconomic forces and geopolitical dynamics continue to shape the M&A and investment climate globally, health and life sciences transactions continue to remain high priority sectors presenting both high growth and defensive asset strategies.

As the market has tightened, understanding the...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Govt Agencies, Investments, Mergers & Acquisitions / JV, Regulations, Trends
Wearable heart device company to go public, raise up to $155M
NHI Targets More SHOP Growth in 2025, With ‘Good Momentum’ Thus Far
Investing In AI Models Is Dead, Why VCs Are Betting On Human Interfaces
Follow the Money: 3D Spatial Biology, AI-Powered Imaging Biomarkers, More
Eikon raises $351M in one of the year’s largest biotech venture rounds

Share This Article